Opioid agonist therapy
Comment on
-
Primary care management of opioid use disorders: Abstinence, methadone, or buprenorphine-naloxone?Can Fam Physician. 2017 Mar;63(3):200-205. Can Fam Physician. 2017. PMID: 28292795 Free PMC article. Review.
References
-
- Connock M, Juarez-Garcia A, Jowett S, Frew E, Liu Z, Taylor RJ, et al. Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. Health Technol Assess. 2007;11(9):1–171. - PubMed
-
- Schuckit MA. Treatment of opioid-use disorders. N Engl J Med. 2016;375(4):357–68. - PubMed
-
- Fiellin DA, Moore BA, Sullivan LE, Becker WC, Pantalon MV, Chawarski MC, et al. Long-term treatment with buprenorphine/naloxone in primary care: results at 2–5 years. Am J Addict. 2008;17(2):116–20. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources